11/21/2024
7:27 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G | |
11/19/2024
6:59 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:57 AM | Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
11/18/2024
8:57 PM | Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
11/14/2024
5:04 PM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
6:08 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:00 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/15/2024
8:49 PM | Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
10/15/2024
6:20 PM | Boxer Asset Management Inc. (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
09/30/2024
8:00 AM | iTeos Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
09/16/2024
6:00 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:00 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:08 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
6:16 AM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2024
6:19 AM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Iannone Robert (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
RHOADS ANN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Hallal David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Ho Tony W (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:01 PM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:37 AM | Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
05/14/2024
8:32 PM | Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
LEWIS JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
8:06 PM | iTeos Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
8:10 PM | iTeos Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
05/13/2024
6:01 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
3:35 PM | iTeos Therapeutics (Filer)
| Form 424B5 | |
05/10/2024
7:31 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
6:13 AM | iTeos Therapeutics (Filer)
| Form ARS | |
04/25/2024
6:03 AM | iTeos Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
6:07 AM | iTeos Therapeutics (Filer)
| Form DEFA14A | |
03/08/2024
6:57 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
6:58 PM | iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:00 PM | Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
7:01 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
7:00 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/07/2024
7:01 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:09 AM | iTeos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Shocking footage from Bill Gates’ $100,000,000,000 AI Bet (Ad) If you missed out on Nvidia, watch this video I just made. Click here for full details. |
03/06/2024
6:19 AM | iTeos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/16/2024
11:54 AM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G | |
02/14/2024
8:45 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G/A | |
01/10/2024
4:00 PM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
3:26 PM | iTeos Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
12/07/2023
7:20 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:21 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:22 PM | Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:22 PM | iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:16 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/07/2023
7:17 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
